Targeting prominin2 transcription to overcome ferroptosis resistance in cancer is a research paper published in EMBO Molecular Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 77 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | NIH | NCI | Basic Research Laboratory
Grant: CA218085
American Cancer Society
Grant: 130451‐PF‐17‐105‐01‐CSM
NCI NIH HHS
Grant: R01 CA218085
MeSH Terms
Keywords